Summary of Monitoring Guidance for Islet Autoantibody-Positive Pre-Stage 3 Type 1 Diabetes (T1D)
A summary of the Breakthrough T1D Consensus Guidance for Monitoring Individuals with Islet Autoantibody-Positive Pre-Stage 3 Type 1 Diabetes (Phillip M et al., Diabetes Care, 2024), endorsed by international diabetes experts and societies including the ADA, ISPAD, and the Endocrine Society. A stage-stratified monitoring framework for AAb-positive children and adults is presented, including age-specific HbA1c and self-monitoring blood glucose assessment frequencies (SMBG), and guidance on psychosocial support integration across the care continuum. The roles of multidisciplinary care team members in support of individuals identified through screening programs are also defined. Serving as a clinical reference for HCPs managing patients in the presymptomatic T1D window.
MAT-US-2605738 v1.0-P Exp Date: 05/26/2028